These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2844173)

  • 41. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A putative met-enkephalin releaser, kyotorphin enhances intracellular Ca2+ in the synaptosomes.
    Ueda H; Yoshihara Y; Takagi H
    Biochem Biophys Res Commun; 1986 Jun; 137(2):897-902. PubMed ID: 2425804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of two distinct kyotorphin-hydrolyzing enzymes in rat brain.
    Akasaki K; Nakamura A; Shiomi H; Tsuji H
    Neuropeptides; 1991 Oct; 20(2):103-7. PubMed ID: 1798437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and characterization of a calcium-activated neutral protease from rabbit skeletal muscle which requires calcium ions of microM order concentration.
    Inomata M; Hayashi M; Nakamura M; Imahori K; Kawashima S
    J Biochem; 1983 Jan; 93(1):291-4. PubMed ID: 6302094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of activity of calcium activated neutral protease.
    Suzuki K; Imajoh S; Emori Y; Kawasaki H; Minami Y; Ohno S
    Adv Enzyme Regul; 1988; 27():153-69. PubMed ID: 2854947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fragmentation of an endogenous inhibitor upon complex formation with high- and low-Ca2+-requiring forms of calcium-activated neutral proteases.
    Nakamura M; Inomata M; Imajoh S; Suzuki K; Kawashima S
    Biochemistry; 1989 Jan; 28(2):449-55. PubMed ID: 2540798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation and characterization of monoclonal antibodies against calcium-activated neutral protease with low calcium sensitivity.
    Kasai Y; Inomata M; Hayashi M; Imahori K; Kawashima S
    J Biochem; 1986 Jul; 100(1):183-90. PubMed ID: 3020013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human mu CANP and mCANP.
    Saito K; Nixon RA
    Neurochem Res; 1993 Feb; 18(2):231-3. PubMed ID: 8474564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue distribution of an endogenous inhibitor of calcium-activated neutral protease and age-related changes in its activity in rats.
    Nakamura M; Imahori K; Kawashima S
    Comp Biochem Physiol B; 1988; 89(2):381-4. PubMed ID: 2833375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium-activated neutral proteinase in rat brain myelin and subcellular fractions.
    Chakrabarti AK; Yoshida Y; Powers JM; Singh I; Hogan EL; Banik NL
    J Neurosci Res; 1988 Jul; 20(3):351-8. PubMed ID: 2852261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of two new calcium dependent hydrolases in the human heart.
    Ikeda U; Toyo-Oka T; Hosoda S
    Biochem Biophys Res Commun; 1986 Apr; 136(2):773-7. PubMed ID: 3010997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
    Hazato T; Kase R; Ueda H; Takagi H; Katayama T
    Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Met-enkephalin releaser (kyotorphin)-induced release of plasma membrane-bound Ca2+ from rat brain synaptosomes.
    Ueda H; Fukushima N; Yoshihara Y; Takagi H
    Brain Res; 1987 Sep; 419(1-2):197-200. PubMed ID: 3676725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure and function of the small (30K) subunit of calcium-activated neutral protease (CANP).
    Suzuki K; Emori Y; Ohno S; Imahori S; Kawasaki H; Miyake S
    Biomed Biochim Acta; 1986; 45(11-12):1487-91. PubMed ID: 3034236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of calcium-activated neutral protease (CANP)-associated protein kinase from bovine brain and its phosphorylation of neurofilaments.
    Zimmerman UJ; Schlaepfer WW
    Biochem Biophys Res Commun; 1985 Jun; 129(3):804-11. PubMed ID: 2990469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinase activities associated with calcium-activated neutral proteases.
    Zimmerman UJ; Schlaepfer WW
    Biochem Biophys Res Commun; 1984 May; 120(3):767-74. PubMed ID: 6329183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteolysis of the epidermal growth factor receptor by endogenous calcium-activated neutral protease from rat liver.
    Gates RE; King LE
    Biochem Biophys Res Commun; 1983 May; 113(1):255-61. PubMed ID: 6305351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kyotorphin synthetase activity in rat adrenal glands and spinal cord.
    Kawabata A; Muguruma H; Tanaka M; Takagi H
    Peptides; 1996; 17(3):407-11. PubMed ID: 8735966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.
    Sato S; Yanagisawa K; Miyatake T
    Neurochem Res; 1984 May; 9(5):629-35. PubMed ID: 6206410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium-activated neutral protease (CANP) in normal and dysmyelinating mutant paralytic tremor rabbit myelin.
    Domańska-Janik K; de Nechaud B; Inomata M; Kawashima S; Zalewska T
    Mol Chem Neuropathol; 1992 Jun; 16(3):273-88. PubMed ID: 1418220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.